mpagliflozin is a prescription medication primarily used to manage type 2 diabetes. It belongs to a class of drugs called SGLT2 inhibitors (Sodium-Glucose Cotransporter-2 inhibitors). Empagliflozin works by blocking a protein in the kidneys that reabsorbs glucose back into the blood, allowing excess glucose to be excreted in urine, thus lowering blood sugar levels.

Besides its use in diabetes management, Empagliflozin may also be prescribed to reduce the risk of heart failure and improve outcomes for individuals with heart disease.